Peptonic Medical (publ) announces that the distribution agreement with medtech company GMS Healthcare Group in the United Arab Emirates (UAE) expands with three additional VagiVital® products.
PEPTONIC Medical AB announces that the company has signed a license agreement with Swiss medical technology company Prima Lab SA regarding self-tests for urinary tract
Peptonic Medical AB (publ) today announced that the company has signed an exclusive agreement with Cetro Medical for distribution of VagiVital VS Pro and VagiVital AL
GROUP 2022 FIRST QUARTER (jan-mar) Word from our CEO It is with great joy we can report that the positive development of the core business,
Peptonic Medical (PMED:SS) today announced that it has signed a non-exclusive agreement with the medical technology company Siemens Healthineers for the distribution of Peptonic’s portfolio of diagnostic
Peptonic Medical (publ) today announced that Apotek Hjärtat is initiating sales of the company’s leading intimate care product VagiVital® AktivGel in most of its physical
